IBM:NYSEInternational Business Machines Corporation Analysis
Data as of 2026-05-19 - not real-time
$222.75
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
IBM is navigating a bearish technical landscape, with the price trading below its short‑term and medium‑term moving averages, a neutral‑to‑slightly‑oversold RSI, and a bearish MACD histogram. Decreasing volume and elevated 30‑day volatility add pressure, while the stock hovers just above a key support zone and faces a sizable resistance barrier.
On the fundamentals side, IBM delivers solid top‑line growth and robust profitability, highlighted by strong gross and operating margins and an exceptionally high return on equity. The company generates ample cash flow to comfortably cover its dividend, which offers a healthy yield, though its balance sheet is weighted heavily toward debt. Analyst sentiment remains positive with a consensus buy and upside potential relative to current pricing, supported by strategic AI and hybrid‑cloud initiatives.
On the fundamentals side, IBM delivers solid top‑line growth and robust profitability, highlighted by strong gross and operating margins and an exceptionally high return on equity. The company generates ample cash flow to comfortably cover its dividend, which offers a healthy yield, though its balance sheet is weighted heavily toward debt. Analyst sentiment remains positive with a consensus buy and upside potential relative to current pricing, supported by strategic AI and hybrid‑cloud initiatives.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical indicators
- Decreasing trading volume
- Proximity to near‑term support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings growth and cash generation
- Attractive dividend yield
- Analyst consensus and upside to target price
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic positioning in AI and hybrid cloud
- Sustainable dividend income
- Resilient profitability despite high leverage
Key Metrics & Analysis
Financial Health
Revenue Growth9.50%
Profit Margin15.61%
P/E Ratio19.7
ROE35.77%
ROA5.37%
Debt/Equity211.17
P/B Ratio6.3
Op. Cash Flow$14.0B
Free Cash Flow$13.1B
Industry P/E38.2
Technical Analysis
TrendBearish
RSI41.9
Support$212.34
Resistance$258.09
MA 20$229.26
MA 50$238.85
MA 200$270.22
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Fair Value$208.06
Target Price$278.18
Upside/Downside24.88%
GradeFair
TypeBlend
Dividend Yield3.03%
Risk Assessment
Beta0.98
Volatility36.90%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.